SCHEMBL16241968

SCHEMBL16241968

[CH2][SiH](c1ccccc1)c1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.37
TDP1 Q9NUW8 5/20 0.37
HSD17B10 Q99714 3/20 0.37
CTSD P07339 1/20 0.37
TSHR P16473 8/20 0.35
PTGS2 P35354 2/20 0.35
ALOX12 P18054 2/20 0.35
ALOX15 P16050 1/20 0.35
PTGS1 P23219 1/20 0.35
SLC6A2 P23975 1/20 0.35
MAPK1 P28482 1/20 0.35
HTR2B P41595 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
IDO1 P14902 2/20 0.33
LMNA P02545 2/20 0.33
DAO P14920 1/20 0.33
NAPRT Q6XQN6 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL703210 0.71 ALDH1A1 (0.35) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL3482296 0.69 ALDH1A1 (0.40) ALDH1A1TDP1HSD17B10CTSDTSHR
Benzene SCHEMBL27873242 0.69 ALDH1A1 (0.40) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL38902 0.69 ALDH1A1 (0.40) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL11588969 0.67 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL11256956 0.67 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CTSDTSHR
Ammonia Solution, Strong SCHEMBL3895204 0.67 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL10422510 0.67 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL38651919 0.67 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CTSDTSHR
SCHEMBL11589221 0.67 ALDH1A1 (0.38) ALDH1A1TDP1HSD17B10CTSDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140371459-A1 INDUSTRIAL PROCESS FOR PREPARATION OF 1,2-DIHYDROQUINOLINE DERIVATIVE OR A SALT THEREOF, AND INTERMEDIATE FOR PREPARATION THEREOF SANTEN PHARMACEUTICAL CO., LTD. (JP) 2014-12-18 US disclosed
EP-2805948-A1 INDUSTRIAL PROCESS FOR PREPARATION OF 1,2-DIHYDROQUINOLINE DERIVATIVE OR A SALT THEREOF, AND INTERMEDIATE FOR PREPARATION THEREOF Santen Pharmaceutical Co., Ltd (JP) 2014-11-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371459-A1 INDUSTRIAL PROCESS FOR PREPARATION OF 1,2-DIHYDROQUINOLINE DERIVATIVE OR A SALT THEREOF, AND INTERMEDIATE FOR PREPARATION THEREOF NR3C2, NR5A1, NR3C1 ALDH1A1 1415/4885TDP1 4238/4885HSD17B10 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.